- Medical - Distribution
- Healthcare
-
22.97
EPS
-
26.13
P/E
-
77.8B
MARKET CAP
-
0.41%
DIV YIELD
Company Overview
6555 STATE HIGHWAY 161,IRVING TX 75039,972-446-4800
CEO
Mr. Brian S. Tyler Ph.D.
Employess
45000
Sector
Healthcare
Industry
Medical - Distribution
Website
https://www.mckesson.com
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Next Earnings Date
Oct. 30, 2024
Ex Dividends date
Jul. 01, 2024
Dividend Date
June 3, 2024
YTD Performance
26.77%
Fiscal Year End
03-31
IPO Date
1994-11-10
Growth Rates
(avg. rate of change) | 10 years | 5 years | 3 years | 1 year |
---|---|---|---|---|
Sales/Revenue | 8.42% | 7.59% | 9.05% | 11.65% |
EPS | 15.13% | 165.77% | 41.52% | -10.66% |
Equity | -2.10% | -4.46% | -354.45% | -6.14% |
Cash | 0.90% | 8.99% | -9.95% | -1.99% |
Return On Capital (ROIC) | 29.30% | 46.23% | 62.50% | 86.41% |
Debt
year (millions) | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Short Term Debt | 345 | 1,270 | 1,100 | 1,130 | 1,410 |
Long Term Debt | 5,420 | 6,030 | 6,450 | 8,270 | 8,000 |
LT Finance Leases | 1,630 | 1,700 | 1,660 | 2,260 | 2,010 |
Shares Outstanding | 133 | 141 | 152 | 161 | 181 |
Market Cap | 71,500 | 50,200 | 46,600 | 31,300 | 24,500 |
Price
News
McKesson (MCK) Increases Yet Falls Behind Market: What Investors Need to Know
2 monthsIn the latest trading session, McKesson (MCK) closed at $600.16, marking a +0.74% move from the previous day.
zacks.comMcKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It
2 monthsMcKesson (MCK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
zacks.comMcKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know
2 monthsMcKesson (MCK) closed at $585.74 in the latest trading session, marking a +0.47% move from the prior day.
zacks.comMcKesson (MCK) Gains 26% Year to Date: What's Backing the Rally?
2 monthsMcKesson's (MCK) shares have risen 1.5% year to date on the back of solid fundamentals. Increasing volumes of prescription and specialty drugs boost the top line.
zacks.comHere's Why McKesson (MCK) is a Strong Value Stock
2 monthsWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zacks.com3 Reasons Why You Should Hold McKesson (MCK) Stock for Now
2 monthsMcKesson's (MCK) robust Biologics business raises optimism about the stock.
zacks.comMcKesson (MCK) Declines More Than Market: Some Information for Investors
2 monthsIn the latest trading session, McKesson (MCK) closed at $575.23, marking a -1.98% move from the previous day.
zacks.comHere's Why McKesson (MCK) is a Strong Momentum Stock
2 monthsWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.comInvestors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know
2 monthsRecently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
zacks.comWhy McKesson (MCK) is a Top Value Stock for the Long-Term
3 monthsWondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
zacks.comHere is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
3 monthsZacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
zacks.comMcKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
3 monthsIn the latest trading session, McKesson (MCK) closed at $599.56, marking a -0.8% move from the previous day.
zacks.com